Sonablate | Top Surgical Solutions Company 2022

MedTech Outlook Magazine

Sonablate
Precision-Driven Care through High-Intensity Focused Ultrasound

Karen Cornett, VP, Clinical Operations, SonablateKaren Cornett, VP, Clinical Operations
Prostate cancer is the leading cancer among men, with one man in eight diagnosed with the disease in their lifetime. While surgery and radiation are the most routine forms of treatment for prostate cancer, these treatments are known to cause erectile dysfunction, incontinence, and require extensive recovery post procedure. Currently there is a growing interest in the urology community to support the use of focal therapy to treat prostate cancer. Unfortunately, not all focal therapy treatments are the same, varying in precision and customizability.

Offering the most customizable and precise focal therapy treatment is Sonablate HIFU. The Sonablate HIFU device uses high-intensity focused ultrasound (HIFU) to help physicians specifically target the diseased tissue and treat only the affected portion of the prostate.



“Sonablate HIFU enables physicians to offer their patients oncological control as well as the ability to maintain quality of life.” says Karen Cornett, VP of Clinical Operations at Sonablate Corp.

Akin to how a magnifying glass can focus sun rays to burn a piece of paper, Sonablate HIFU uses ultrasound waves to target the desired area of tissue for treatment. When converging at a spot, the ultrasound waves concentrate energy to create an ablation site, while the intervening tissue around the focus area remains unharmed. As more data emerges on targeted focal therapies for prostate cancer, physicians can continue to rely on advanced imaging to find the often-ignored middle ground between the extremes of active surveillance (when treatment is deferred but the disease is monitored closely) and surgery or radiation.
Sonablate HIFU offers benefits that other focal therapy treatments do not offer. The device is highly customizable which allows physicians to tailor treatment to a patient’s specific prostate anatomy. The device provides innovative, real time ultrasound-derived feedback before and throughout treatment. Before energy delivery, Sonablate HIFU provides a set of reference images that are viewable onscreen throughout the treatment, allowing the physician to compare changes in energy delivery. This enables physicians to continually reassess and customize energy delivery to the prostate tissue at any time, assuring the best outcome.



In addition to being highly customizable and provide real-time feedback, Sonablate HIFU provides several built in safety features, such as the ability to detect gray scale changes that normally escape the human eye. Upon detection, Sonablate HIFU alerts the physician so they can halt the ongoing treatment and make the necessary changes.

  • Compared to the difficult-to-control ablation tool of cryotherapy that rarely offers true precision, HIFU, with an almost rice grain-sized ablation site, is much more targeted and precise


The company’s vision is to transform sound energy into focused healing. “Compared to the difficult-to-control ablation tool of cryotherapy that rarely offers true precision, HIFU, with an almost rice grain-sized ablation site, is much more targeted and precise,” says Cornett.

Focal therapy is poised to become the go-to procedure for managing many cases of prostate cancer. At the forefront of this worldwide transition is Sonablate Corp., continuously bridging the precision gap in prostate disease treatment with its innovative HIFU technologies.

Top 10 Surgical Solutions Companies - 2022

Company
Sonablate

Management
Karen Cornett, VP, Clinical Operations and Nicole Hill, Director of Marketing

Description
Sonablate is a manufacturer of next generation medical equipment, utilizing high intensity focused ultrasound as an alternative for prostate ablation procedures.

Sonablate News

Sonablate HIFU Now Available to Patients at AdventHealth Zephyrhills

CHARLOTTE - Sonablate Corp., announced that Dr. Bertram Lewis has treated his first Sonablate HIFU patients at AdventHealth Zephyrhills in Zephyrhills, Florida.
AdventHealth Zephyrhills has built a strong reputation for its unwavering dedication to offering outstanding healthcare services and remaining at the forefront of medical advancements. The inclusion of Sonablate HIFU as a treatment option signifies a significant achievement in their mission to provide top-quality care to patients residing in Pasco County.
Sonablate HIFU is an outpatient procedure known for its minimal invasiveness, which utilizes high intensity focused ultrasound (HIFU) waves to accurately target and eliminate cancerous cells in the prostate gland. By concentrating intense energy on specific areas, this treatment eradicates diseased cells while preserving healthy tissue and minimizing the likelihood of adverse effects commonly associated with conventional therapies.
"We are thrilled Dr. Bertram Lewis and AdventHealth Zephyrhills brought our innovative Sonablate HIFU technology to patients in Pasco County," said Richard Yang, Chief Executive officer of Sonablate Corp. "This partnership will ensure that individuals seeking treatment for prostate disease have access to the most advanced and effective options available."
Dr. Bertram Lewis shared his excitement, stating, "With the introduction of Sonablate HIFU as one of our treatment options, we can offer patients a precise and minimally invasive alternative. We take pride in bringing this advanced technology to our community, aiming to enhance the well-being of men throughout their healthcare experience."
By including Sonablate HIFU in their range of treatments, AdventHealth Zephyrhills reaffirms their dedication to prioritizing patient needs and guaranteeing the availability of innovative therapies that maximize results and enhance overall well-being.